6
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Patent Update: Agents for the Treatment of Neurodegenerative Diseases: Recent Advances, July Through December, 1992

Pages 251-283 | Published online: 03 Mar 2008

Key References

  • US OFFICE OF TECHNOLOGY ASSESSMENT.
  • KHACHATURIAN ZS: Arch. Neurol. (1985) 42:1097–1105.
  • FARLOW M, GHErn B, BENSON MD, FARROW JS, VANNOSTRAND WE, WAGNER SL: Lancet (1992) 340(8817):453–454.
  • HAASS C, SCHLOSSMACHER MG, HUNG AY, VIGOPELFREY C, MELLON A, OSTASZEWSKI BL, LIEBERBURG I, KOO EH, SCHENK D, TEPLOW DB, SELKOE DJ: Nature (1992) 359(6393):322–325.
  • VERMERSCH P, FRIGARD B, DAVID JP, FALLET-BIANCO C, DELACOURTE A: Neuroscience Let-ters (1992) 144(1–2):143–146.
  • KALARIA RN, KRooN SN, GRAHOVAC 1, PERRY G: Neuroscience (1992) 51(1):177–184.
  • EDLUND C, SODERBERG M, KRISTENSSON K, DALLNER G: Biochemistry and Cell Biology (1992) 70(6):422–428.
  • HAN SY, SWEENEY JE, BACHMAN ES, SCHWEI-GER EJ, FROLONI G, COYLE JT, DAVIS BM, SCHAPIRA AHV, MANN VM, COOPER JM, KRIGE D, JENNER PJ, MARSDEN CD: Annals of Neurology (1992) 32(Suppl.):S116–124.
  • TOHGHI, ABE T, TAWSHI S, KIMURA M: Neuroscience Letters (1992) 141(1):5–8.
  • FISHERG H, DANELLOA, VEPE A, CUSANO GP, CHAvEz M, PETRUCELLLI : Neuroscience Letters ( 1 992) 143( 1–2) : 21 5–2 1 8.
  • LEWIS JM: Neuroepidemiology (1992) 11(3):163–8
  • LEVIT AJ, KARLLNSKY H: Acta Psychiatrica Scandinavica (1992) 86(4):301–305.
  • HOWARDJ, PILKINGTOGNJ : Neuroreport (1992) 3(7):615–618.
  • LANDSBERG JP, MCDONALDB, WAn F: Nature (1992) 360(6399):65–68.
  • DEDMAND J, TREFFRYA, CANDYJ M, TAYLOR GAA, MORRISC M, BLOXHAMC A, PERRYR H, EDWARDSONJA, HARRISONP M: Biochemical Journal (1992) 287(2):509–514.
  • CONSTANTINIDJ:I SD rug Development Research (1 992) 27(1): 1–1 4.
  • DARTIGUESJF, GAGNONM, MICHELP, LETENNEUR L, COMMENCES D, BARBERGERG ATEAU P, AURIACOMBE S, RIGAL B, BEDRY R, ALPEROVITCHA : Rev. Neurol. (1991) 147(3):225–230.
  • STERN Y, ALEXANDEGRE, PROHOVNIKI, MAYEUX R: Annals of Neurology (1992)
  • BEARD CM, KOKMEN E, OFFORD Kp, KURLAND LT Neurology (1 992) 42( 11):2063-2068.
  • JONES GMM, SAHAKIAN BJ, LEVY R, WARBURTON DM, GRAY JA Psychopharmacology O m o w CW Annals of Neurology (1992) 32(3):371–375.
  • DEXTERD T, JENNERP, SCHAPIRAAH V, MARSDEN 32(Suppl.):2–9.
  • DEXTERD T, JENNERP, SCHAPIRAAH V, MARSDEN CD: Annals of Neurology (1992) 32(Suppl.): S94–100.
  • HIRSCH EC: Annals of Neurology (1992) 32(Suppl.):S105–110.
  • BENSHACHADR, ESHELG, RIEDERERP, YOUDIM MBH: Annals of Neurology (1992) 32(Suppl.):S105–100.
  • GOOD PF, OLANOW CW, PERL DP: Brain Research (1992) 593(2):343–6.
  • YASUI M, KrHIRA T, OTA K: Neurotoxicology (1 992) 13(3):593–600.
  • JENNER P, DEXTER DT, SIAN J, SCHAPIRA AHV, MARSDEN CD: Annals of Neurology (1 992) 32(S~ppl.):S82–87.
  • DIAMNOTE DA, C M P, SANDY MS: Annals of Neurology (1992) 32(Suppl.):S 111-1 15.
  • FAHN S: Annals of Neurology (1992) 32(Suppl.): S128–132.
  • SCHAPIRA AHV, MANN VM, COOPER JM, KRIGE D, JENNER PJ, Marsden CD: Annals of Neurology (1992) 32(Suppl.):S116–124.
  • Ogawa T, Matson WR, Beal MF, Myers RH, BIRD ED, MlLBURY P, SaSO S: Neurology (1992)42:1702–1706.
  • IWASAKI Y, Ikeda K, Shiojima T, Kinoshita M: Neuroscience Letters (1992) 145(2): 175–177.
  • WULLNER U, KUPSCH A, ARNOLD G, RENNER P, SCHEID C, OERrEL W, KLOCKGETHER T: Neuropharmacology (1992) 31(7):713–715.
  • PEARSON SJ, REYNOLDS GP: Neuroscience Letters (1992) 144(1–2): 199–201.
  • MAYER RJ, LANDON M, LASZLO L, LENNOX G, LOWE J: Lancet (1992) 340(8812):156–159.
  • ROTHSTEIN JD, MARTIN LJ, KUNCL RW: New Engl J. Med. (1992) 1464–1468.
  • SLMANTOV R: Neuroscience Research Communications (1992) 11(1):45–51.
  • Russi P, Alesiani M, Lombardi G, Davolio P, Pellicciari R, Moroni F: Journal ofNeu-rochemistry (1992) 59(6):2076–2080.
  • KISKIN Nl, CHIZHMAKOV IV, TSYNDRENKO AY, MUELLER AL, JACKSON H, KRISHTAL OA: Neuroscience (1992) 51(l):ll–38.
  • MELDRUM BS: Epilepsy Research (1992) 12(2): 189–96.
  • Lannes B, Micheletti G, Warter JM, ZwiLLER J: Comptes Rendus de L'Academic Des SciencesSerie III (1992) 315(l)):387–394.
  • Bridges RJ, Hatlaski CG, Shim SN, Cumm-INGS BJ, VlJAYAN V, KUNDI A, COTMAN CW: Neuropharmacology (1992) 31(9):899–907.
  • McDonald JW, Johnston MV: Neuroscience Letters (1992) 145(2):213–216.
  • This review cites only (hose patents which either presented data to support potential activity or disclosed relatively unexplored potential mechanisms for neuroprotection.
  • BAUDY RB: Curr Opin. Thera. Patents (1992) 2(8): 1261–1280.
  • REYNOLDS et aL: Proc. Natl. Acad. Set. USA (1987)84:7744–7748.
  • LUZZI et aL: British J. Pharmacol. (1989) 95:1271–1277.
  • BARON et aL: J. Pharmacol. Exp. Ther. (1989) 250:162.
  • HAHN et aL: Proc. Natl. Acad. ScL USA (1988) 85:6556.
  • ELLMAN et aL: Biochem. Pharmacol. (1961) 7:88–95.
  • HUNTER & ROBERTS: Pharmacol. Biochem. and Behaviour (1988) 30:519–523.
  • MCLEAN JR: PharmacoL Biochem. and Be-haviour (1978) 8:97–99.
  • SEEMAN P: J. Neurochem. (1985) 44:1925–1935.
  • MAYER et al.: J. Neurochem. (1986) 47:1073.
  • EUR. J. PharmacoL (1985) 106:455.
  • FURUKAWA et al.: J. Neurochem. (1983) 44:734–744.
  • REEVES et al.: Brit. J. Pharmacol. (1989) 98:800.
  • TAYLOR et al.: J. PharmacoL Exp. Ther (1986) 236:118–125.
  • CATALL et al.: PharmacoL Biochem. Behaviour (1989) 33:197.
  • GOODMAN et al.: MoL PharmacoL (1982) 21:329–335.
  • BRUNS et al.: MoL PharmacoL (1986) 29:331–346.
  • REEVES et al.: Biochem. J. (1987) 241:535.
  • BARNES et al.: PharmacoL Biochem. Be-haviour (1990) 35:955–962.
  • FJALLAND: Acta PharmacoL ToxicoL (1978) 42:73–76.
  • TIPTON KF et al.: Biochem J. (1968) 108:95–99.
  • BRAUGHLER J et aL: J. Biol. Chem. (1986) 261:10282–10289.
  • OJ1KA K et aL: Drug, Spirit, Action (1985) 7:447.
  • STERU et al.: Prog. Neuro-PsychopharmacoL Biol. Psychiatry (1987) 11:659–671.
  • DAN'TZER et al.: PsychopharmacoL (1987) 91:363–368.
  • LAPIN: J. Neural Transmission (1982) 54:229–238.
  • CHERMAT & SIMON: J. PharmacoL Paris (1975) 6:489–492.
  • FIELDS: Brain Res. (1977) 136:578.
  • HALL: J. Neurochem. (1985) 44:1685.
  • MCDONALD JW: Brain Res. (1988) 459:200–203.
  • WEISS: PharmacoL Biochem. Behaviour (1988) 30:309–317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.